| P2093 | author name string | Yuan Yang | |
| | Susan Hua | |
| | Thilani H Dias | |
| | Debbie-Gai Pepperall | |
| P2860 | cites work | Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine | Q22248084 |
| | Opioid therapy for treating rheumatoid arthritis pain | Q24235173 |
| | Mast cells in inflammatory arthritis | Q24798636 |
| | Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis | Q26738338 |
| | Low-dose naltrexone therapy improves active Crohn's disease | Q28283321 |
| | Attacking pain at its source: new perspectives on opioids | Q30047792 |
| | Effects of carrageenan and morphine on acute inflammation and pain in Lewis and Fischer rats | Q48589401 |
| | The neural cell adhesion molecule antibody blocks cold water swim stress-induced analgesia and cell adhesion between lymphocytes and cultured dorsal root ganglion neurons | Q48641795 |
| | Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. | Q48784173 |
| | Targeting inflammation and wound healing by opioids. | Q51059076 |
| | Intraarticular morphine versus dexamethasone in chronic arthritis | Q56990775 |
| | Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis | Q58042940 |
| | Analgesic effect of intraarticular morphine after arthroscopic knee surgery | Q68253539 |
| | The anti-inflammatory effect of opioids | Q72721721 |
| | Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages | Q73176412 |
| | Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority | Q74714748 |
| | Opioids for nonmalignant pain | Q81664817 |
| | Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain | Q86036539 |
| | The role of substance P in inflammatory disease | Q34343982 |
| | Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy | Q34497135 |
| | Loperamide Abuse Associated With Cardiac Dysrhythmia and Death | Q34524773 |
| | VEGF and imaging of vessels in rheumatoid arthritis | Q34731141 |
| | Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis | Q35027644 |
| | Anti-inflammatory effects of opioids | Q35078254 |
| | Epidemiology and burden of illness of rheumatoid arthritis | Q35780338 |
| | Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis | Q35954556 |
| | micro-Opioid receptor activation prevents acute hepatic inflammation and cell death | Q36014007 |
| | Leukocytes in the regulation of pain and analgesia | Q36276607 |
| | Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population | Q36763024 |
| | Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases | Q37074962 |
| | Mechanisms of peripheral immune-cell-mediated analgesia in inflammation: clinical and therapeutic implications | Q37768964 |
| | Loperamide | Q37894244 |
| | Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis | Q37980338 |
| | Non-analgesic effects of opioids: peripheral opioid effects on inflammation and wound healing | Q38022721 |
| | Opioids for the treatment of arthritis pain | Q38166805 |
| | Synovial tissue hypoxia and inflammation in vivo | Q39708042 |
| | Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea | Q39716535 |
| | Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation | Q39750331 |
| | Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism | Q39838413 |
| | Opioids and differentiation in human cancer cells | Q40372168 |
| | Analgesic effects of loperamide in bone cancer pain in mice | Q40422510 |
| | Women with established rheumatoid arthritis perceive pain as the predominant impairment of health status | Q40590333 |
| | Immune cell-derived opioids protect against neuropathic pain in mice | Q41778873 |
| | Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia. | Q41864750 |
| | Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery | Q41917770 |
| | Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions | Q41962056 |
| | Methionine-enkephalin modulation of hydrogen peroxide (H2O2) release by rat peritoneal macrophages involves different types of opioid receptors | Q42524219 |
| | Peripheral analgesic and antiinflammatory effects of opioids | Q43876004 |
| | Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat. | Q44155559 |
| | Opioid analgesics for rheumatoid arthritis pain | Q44337896 |
| | Local analgesic effect of endogenous opioid peptides | Q44338122 |
| | Analgesic action of loperamide, an opioid agonist, and its blocking action on voltage-dependent Ca2+ channels | Q44342256 |
| | Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice | Q44345265 |
| | The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production | Q44346178 |
| | Methionine-enkephalin stimulates hydrogen peroxide and nitric oxide production in rat peritoneal macrophages: interaction of mu, delta and kappa opioid receptors | Q44346942 |
| | Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide | Q44351114 |
| | Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity | Q44351610 |
| | Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride | Q44836238 |
| | Potential utility of peripherally applied loperamide in oral chronic graft-versus-host disease related pain | Q46294906 |
| | Topical opioids for painful ulcers in systemic sclerosis | Q46740212 |
| | Analgesic effects of morphine and loperamide in the rat formalin test: interactions with NMDA receptor antagonists | Q46811859 |
| | Models of inflammation: adjuvant-induced arthritis in the rat. | Q46842174 |
| | Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition | Q48470787 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 503 | |
| P577 | publication date | 2017-08-02 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of Experimental Rheumatoid Arthritis | |
| P478 | volume | 8 | |